Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia
暂无分享,去创建一个
Larry A. Sklar | Stuart L. Schreiber | Anna Waller | Paul A. Clemons | Dongjun Lee | Esha Jain | Kerry A. Pierce | Clary B. Clish | P. Clemons | S. Schreiber | Mathias Wawer | R. Sadreyev | D. Scadden | J. Kotz | C. Clish | A. Waller | L. Sklar | N. Tolliday | T. Lewis | M. Haynes | Dongjun Lee | Y. Kfoury | A. Schajnovitz | K. Pierce | S. Mukherjee | S. Ferrara | David T. Scadden | Joanne D. Kotz | F. Mercier | Andreas Janzer | Siddhartha Mukherjee | Ruslan I. Sadreyev | Timothy A. Lewis | Nicola J. Tolliday | A. Janzer | D. Sykes | Mathias J. Wawer | David B. Sykes | Steven J. Ferrara | J. Cobert | Mark K. Haynes | Youmna S. Kfoury | François E. Mercier | Jason M. Law | Amir Schajnovitz | Hanna Meyer | Ashley L. Eheim | Detlef Stoeckigt | Katrina L. Maxcy | Julien M. Cobert | Jacqueline Bachand | Brian A. Szekely | E. Jain | A. Eheim | Hanna Meyer | D. Stoeckigt | Katrina Maxcy | Jacqueline Bachand | Esha Jain
[1] CT Collins,et al. Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets , 2016, Oncogene.
[2] Nicholas D. Adams,et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. , 2015, Nature chemical biology.
[3] A. Papavassiliou,et al. HOXA9 and MEIS1 gene overexpression in the diagnosis of childhood acute leukemias: Significant correlation with relapse and overall survival. , 2015, Leukemia research.
[4] Tudor I. Oprea,et al. Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes , 2015, Cell.
[5] J. Hanover,et al. A little sugar goes a long way: The cell biology of O-GlcNAc , 2015, The Journal of cell biology.
[6] S. Schreiber,et al. Discovering Small Molecules that Overcome Differentiation Arrest in Acute Myeloid Leukemia , 2015 .
[7] T. Golub,et al. Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors. , 2015, Cell reports.
[8] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[9] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[10] H. Kaufman,et al. Inhibition of p70 S6 Kinase (S6K1) Activity by A77 1726 and Its Effect on Cell Proliferation and Cell Cycle Progress , 2014, Neoplasia.
[11] Peter Kraft,et al. Elevated circulating branched chain amino acids are an early event in pancreatic adenocarcinoma development , 2014, Nature Medicine.
[12] M. Bryś,et al. O-GlcNAcylation and Metabolic Reprograming in Cancer , 2014, Front. Endocrinol..
[13] Paola Fazi,et al. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. , 2013, The New England journal of medicine.
[14] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[15] Fang Wang,et al. Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation , 2013, Science.
[16] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[17] J. Hanover,et al. Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation , 2012, Nature Reviews Molecular Cell Biology.
[18] Charles Y. Lin,et al. DHODH modulates transcriptional elongation in the neural crest and melanoma , 2011, Nature.
[19] N. Friedman,et al. Densely Interconnected Transcriptional Circuits Control Cell States in Human Hematopoiesis , 2011, Cell.
[20] William H. Bisson,et al. The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor , 2010, PloS one.
[21] R. Gentleman,et al. Independent filtering increases detection power for high-throughput experiments , 2010, Proceedings of the National Academy of Sciences.
[22] Omar Abdel-Wahab,et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. , 2010, Cancer cell.
[23] P. Shannon,et al. Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.
[24] Tudor I. Oprea,et al. Detection of Intracellular Granularity Induction in Prostate Cancer Cell Lines by Small Molecules Using the HyperCyt® High-Throughput Flow Cytometry System , 2009, Journal of biomolecular screening.
[25] J. Downing,et al. Mouse models of human AML accurately predict chemotherapy response. , 2009, Genes & development.
[26] T. Ley,et al. Commonly Dysregulated Genes in Murine Apl Cells , 2006 .
[27] Cheng Li,et al. Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.
[28] F. Tedeschi,et al. HOXA9 gene expression in the chronic myeloid leukemia progression. , 2006, Leukemia research.
[29] T. Golub,et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.
[30] C. Wolf,et al. Regioselective copper-catalyzed amination of bromobenzoic acids using aliphatic and aromatic amines. , 2006, The Journal of organic chemistry.
[31] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] Bart De Moor,et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis , 2005, Bioinform..
[33] Rafael A. Irizarry,et al. A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .
[34] E. Raymond,et al. Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies , 1998, Investigational New Drugs.
[35] G. Schuster,et al. Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides , 2004, Molecular and Cellular Biochemistry.
[36] D. V. Cramer. Brequinar sodium , 2004, Pediatric Nephrology.
[37] H. Pinedo,et al. Phase I study of Brequinar sodium (NSC 368390) in patients with solid malignancies , 2004, Cancer Chemotherapy and Pharmacology.
[38] B. Mitchell,et al. A77 1726 induces differentiation of human myeloid leukemia K562 cells by depletion of intracellular CTP pools. , 2002, Molecular pharmacology.
[39] T. Graf,et al. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. , 2000, Blood.
[40] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[41] W. Knecht,et al. Species-related inhibition of human and rat dihydroorotate dehydrogenase by immunosuppressive isoxazol and cinchoninic acid derivatives. , 1998, Biochemical pharmacology.
[42] Unnur Thorsteinsdottir,et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b , 1998, The EMBO journal.
[43] G. Sauvageau,et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[44] L. Grochow,et al. Phase I and pharmacokinetic study of brequinar sodium (NSC 368390). , 1990, Cancer research.
[45] G. Weiss,et al. Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390). , 1989, Cancer research.
[46] P. Chambon,et al. The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. , 1989, The EMBO journal.
[47] J. Griffin,et al. Response of preleukemic syndromes to continuous infusion of low-dose cytarabine. , 1983, The New England journal of medicine.
[48] A. Jakubowski,et al. Pyrazofurin metabolism, enzyme inhibition, and resistance in L5178Y cells. , 1979, Cancer research.
[49] J. Yates,et al. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. , 1973, Cancer chemotherapy reports.
[50] R. Miller,et al. Mammalian dehydroorotate-ubiquinone reductase complex. , 1968, Canadian journal of biochemistry.